Research / FICO / Fundamental state Inspectable configuration
State dimensions Filing 0000814547-24-000016 General Corporate
Debt relative to revenue 75th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
467.64% · OPTIONAL · VALID
Capex intensity 60th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
0.93% · OPTIONAL · VALID
Operating cash generation 0th Own-history percentile · N=18
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
16.37% · OPTIONAL · VALID
Revenue growth 90th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
14.08% · CORE · VALID
Operating margin 95th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
44.91% · CORE · VALID
R&D intensity 0th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
9.42% · OPTIONAL · VALID
SBC intensity 50th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
8.17% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 43 states Self-history eligible
Sep 30, 2021 7/7 normalized Level 3 Dec 31, 2021 7/7 normalized Level 3 Mar 31, 2022 7/7 normalized Level 3 Jun 30, 2022 7/7 normalized Level 3 Sep 30, 2022 6/6 normalized Level 3 Dec 31, 2022 7/7 normalized Level 3 Mar 31, 2023 7/7 normalized Level 3 Jun 30, 2023 7/7 normalized Level 3 Sep 30, 2023 6/6 normalized Level 3 Dec 31, 2023 7/7 normalized Level 3 Mar 31, 2024 7/7 normalized Level 3 Jun 30, 2024 7/7 normalized Level 3 Sep 30, 2024 6/6 normalized Level 3 Dec 31, 2024 7/7 normalized Level 3 Mar 31, 2025 7/7 normalized Level 3 Jun 30, 2025 7/7 normalized Level 3 Sep 30, 2025 7/7 normalized Level 3 Dec 31, 2025 7/7 normalized Level 3 Mar 31, 2026 7/7 normalized Level 3 Jun 30, 2026 7/7 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 473.40%
Current 467.64%
Delta -5.76% Capex Intensity Increased
Previous 0.36%
Current 0.93%
Delta 0.58% Cash Generation Decreased
Previous 31.96%
Current 16.37%
Delta -15.59% Growth Increased
Previous 10.78%
Current 14.08%
Delta 3.30% Profitability Increased
Previous 39.62%
Current 44.91%
Delta 5.30% R And D Intensity Decreased
Previous 11.16%
Current 9.42%
Delta -1.74% Sbc Intensity Decreased
Previous 8.26%
Current 8.17%
Delta -0.09% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.